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Outcomes of Assisted Reproductive Techniques for
HIV-1-discordant Couples Using Thawed Washed
Sperm in Taiwan: Comparison With Control and
Testicular Sperm Extraction/Microscopic Epididymal
Sperm Aspiration Groups
Ming-Yih Wu, Li-Jong Chang, Mei-Jou Chen, Kuang-Han Chao, Yu-Shih Yang, Hong-Nerng Ho*
Background/Purpose: An increasing number of human immunodeficiency virus-1 (HIV-1)-discordant
couples in Taiwan have been seeking fertility help. We conducted the first clinical trial in Taiwan of assisted
reproductive technology (ART) using sperm washing and viral load measurement.
Methods: From 2005 to 2009, we performed 22 ART cycles on 14 HIV-1-discordant couples. The sperm
washing involved density gradient centrifugation followed by swim-up method. HIV-1 RNA was checked
by real-time reverse transcription-polymerase chain reaction with a sensitivity of 40 copies/mL. In addi-
tion, we enrolled two other groups of ART recipients using frozen sperm to compare the clinical outcomes.
Results: There were five pregnancies in the fresh cycles (23.8%) of HIV-1-discordant couples and the cumu-
lative pregnancy per couple was 42.9% (6/14). The data were comparable with normal controls and testi-
cular sperm extraction/microscopic epididymal sperm aspiration groups. The nine babies and the 14 women
in this study showed no seroconversion.
Conclusion: The preliminary data showed good ART results in HIV-1-discordant couples. Fertility services
should not be withheld from individuals with HIV-1, although larger series are needed to reach conclusions
about safety.
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In Taiwan, the first case of acquired immunode-
ficiency syndrome (a foreigner in transit) was
identified in December 1984, and recently Taiwan
has shown an increasing incidence of human 
immunodeficiency virus-1 (HIV-1) infection.1
Meanwhile, there has been continual improve-
ment in survival among HIV-infected individuals
through the use of newer forms of highly active
antiretroviral therapy.2 With the achievement of
improved survival rates, married couples now
©2011 Elsevier & Formosan Medical Association
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Received: October 8, 2009
Revised: April 6, 2010
Accepted: July 21, 2010
*Correspondence to: Dr Hong-Nerng Ho, Department of Obstetrics and Gynecology,
National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan.
E-mail: hnho@ntu.edu.tw
M.Y. Wu, et al
496 J Formos Med Assoc | 2011 • Vol 110 • No 8
often wish to have children safely. The clinical
use and risk of sperm washing and its risks were
first reported in 1992 by Semprini et al,3 and
since then it has been confirmed worldwide.4,5 The
guidelines of the American Society for Reproductive
Medicine in 20066 also recommended Semprini’s
widely used sperm-washing procedure: the use
of gradient centrifugation followed by a sperm
swim-up procedure. In the first trial of this proce-
dure in Taiwan, we here present the clinical data
of 14 HIV-1-discordant couples and compare the
results with two other groups [normal controls
and testicular sperm extraction/microscopic epi-
didymal sperm aspiration (TESE/MESA)] who
were also using frozen sperm.
Materials and Methods
Subject couples
The subject couples were seeking reproductive
services and were referred to the Department of
Obstetrics and Gynecology of National Taiwan
University Hospital. HIV-1 infection status of the
couples including CD4+ cells and plasma viral
load was assessed first. Gynecological examina-
tions, including pelvic ultrasound, and hormone
profiles, and semen analysis were subsequently
performed to decide which couples would re-
ceive intrauterine insemination (IUI, not discussed
here) or in vitro fertilization (IVF) cycles. From
2005 to 2009, a total of 14 couples (22 stimu-
lation cycles) were enrolled in this study. The in-
stitutional review board approved this study
(22MD02) in 2003, and signed informed con-
sent was obtained from each couple before they
entered the treatment cycle. The indications for
IVF in these HIV-1-discordant couples were the
same as for other patients.
Semen pretreatment
Semen samples were obtained by masturbation
and then examined for sperm concentration, motil-
ity and morphology. The samples were processed
using a density gradient (three layers at 50%,
70% and 90%, from top to bottom; SpermGrad;
Vitrolife, Kungsbacka, Sweden) to separate motile
spermatozoa from non-sperm cells, immotile sper-
matozoa, and seminal plasma. The ejaculate was
layered over the gradient and centrifuged at 300g
for 20 minutes. After centrifugation, the 50% and
70% layers were eliminated, and the sperm pellet
recovered and resuspended in 2mL of fresh human
tubal fluid medium (home-made, quality con-
trol by mouse embryo culture), divided into four
parts, placed in four test tubes and centrifuged at
200g for 10 minutes. The supernatant was dis-
carded, 0.5 mL of human tubal fluid medium was
subsequently gently layered on the pellet, and the
tube was incubated at 37°C for 1 hour. After swim-
up, a supernatant volume of 350–400 μL was re-
covered per test tube (i.e. 1.4–1.6 mL). One of the
aliquots was tested for detectable HIV-1 RNA.
Detection of HIV-1 RNA in washed semen
A sample of extract (50 μL) was mixed manu-
ally with 50 μL COBAS TaqMan HIV-1 premix
reagent and amplified using the real-time poly-
merase chain reaction (PCR) COBAS TaqMan 48
instrument (COBAS Ampliprep analyzer; Roche
Diagnostics, Meylan, France). Target and internal
quality standards amplified DNA in each sample
were detected and assayed using specific TaqMan
probes. Results were visualized on a computer
using the Amplilink 3.01 system connecting the
COBAS TaqMan 48 and COBAS Ampliprep instru-
ments. The sensitivity ranged from 40 copies/mL
to 10,000,000 copies/mL.
Assisted reproductive technology (ART)
Controlled ovarian hyperstimulation was per-
formed mostly by a long gonadotropin-releasing
hormone agonist protocol or by short protocols
for some poor responders, as previously re-
ported.7 Recombinant follicle-stimulating hor-
mone (Puregon; Organon, the Netherlands) at
200 IU/day was given starting from Day 3 of 
the long protocol or Day 5 of the short protocol.
Ultrasound-guided transvaginal oocyte retrieval
(TVOR) was performed at 34–36 hours after
human chorionic gonadotropin (hCG) admin-
istration. Subsequently, intracytoplasmic sperm
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injection (ICSI) was performed in all 14 cases 
6 hours later.8 Embryo transfer (ET) was con-
ducted on the Day 3 after TVOR. According to the
March 2006 guidelines of the Taiwan Society of
Reproductive Medicine, no more than four em-
bryos could be transferred. Luteal phase was sup-
ported with 1500 IU hCG on Day 2, Day 5 and
Day 8 after transfer, and 25 mg/day progesterone
in oil for 14 days. Clinical pregnancy was defined
by sonographic visualization of a gestational sac,
combined with elevation of serum β-hCG levels.
When focusing on the embryo quality, the aver-
age embryo score9 was calculated by cumulative
embryo score divided by embryo numbers.
Seroconversion tests
Before ART, each patient was screened for HIV-1
negativity. Therefore, all female partners were
HIV negative at the beginning. After ART, all pa-
tients regardless of whether they were pregnant
were tested for HIV-1 antibodies 6 months later.
Furthermore, newborn babies were also tested at
birth or later.
Control couples
To verify the pregnancy rates of the HIV-1-
discordant couples, we enrolled another two
groups using frozen sperm for ICSI during the
same period (2005–2009). The first group was
the normal control group who were using frozen
sperm for personal reasons because the husband
was often abroad for business. The few cases where
we applied IVF were excluded, so we only enrolled
ICSI cases. The second group was the TESE/MESA
group. The sperm specimens were always frozen
because the operation by the urologists might
not match our TVOR schedule. These tiny sam-
ples were stored in aliquots for possible repeated
therapies. All cases in this group received ICSI at
our hospital.
Statistical analysis
For comparison among the three groups, the
Kruskal–Wallis test was applied to most data fol-
lowed by the Mann–Whitney U test. A p value
< 0.05 was considered to be significantly different.
When looking at the success of the pregnancy,
Pearson’s χ2 test was performed to check the 
significance.
Results
Twenty-two fresh cycles of ovarian stimulation
were performed in the 14 HIV-1-discordant cou-
ples (Table 1). Of these, there was one case in
which an oocyte was fertilized but did not show
cleavage, so only 21 cycles of ET were done. The
clinical pregnancy rate per ET was 23.8% (5/21),
which was lower than our routine IVF [in 2008,
our fresh pregnancy rate per ET was 41.9% (218/
520), unpublished data]. All the 14 male partners
had received highly active antiretroviral therapy
for 1–10 years, so all except one had undetectable
plasma viral load (< 40 copies/mL). To date, no
babies or women showed seroconversion during
the follow-up from 14 months to 52 months.
Table 1. Clinical data of in vitro fertilization/
intracytoplasmic sperm injection in 14
human-immunodeficiency-virus-discordant
couples
Patient Spouse 
(n = 14) (n = 14)
Age at first visit (yr) 33.3 ± 4.9 36.1 ± 3.6
Stimulation cycles 22
Fresh clinical pregnancy 23.8% (5/21)a
rate/ET
Thaw clinical pregnancy 33.3% (3/9)
rate/ET
Cumulative pregnancy 42.9% (6/14)
rate/couple
Multiple pregnancy rate 25.0% (2/8)
Ectopic pregnancy rate 12.5% (1/8)
CD4+ > 250/mm3 6/6b
Serum HIV-1 6/7c
< 40 copies/mL
Maternal seroconversion 0
Delivered offspring 0
seroconversion
aOne case had only one oocyte and did not transfer due to no cleavage
of the 2PN embryo; bonly six cases with available CD4 data near the
time of in vitro fertilization; conly seven cases had HIV-1 plasma viral
load data near the time of in vitro fertilization. ET = embryo transfer;
HIV-1 = human immunodeficiency virus-1.
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The PCR results for HIV-1 in washed semen
were available after 12–24 hours. Therefore, we
froze those samples for ICSI. We compared those
samples to those in another two groups using
frozen sperm (Table 2). To eliminate individual
variation, only the first trial of IVF cycles was in-
cluded in these three groups. In the TESE/MESA
group, the patients were younger than in the
control groups (p < 0.05) and the pregnancy rates
seemed to be better than in the control and HIV
groups (but p > 0.05 by Pearson’s χ2 test).
Discussion
The risk of male-to-female transmission of HIV-1
is approximately 0.1% per coital act with HIV-
prevalent index partners.10 However, pregnancy
sometimes cannot be achieved in only one het-
erosexual contact. With unprotected sexual con-
tact near the ovulation period in women in
HIV-1-discordant couples, there is a 4% chance
of viral transmission to achieve one pregnancy.11
If performing IUI using semen from HIV-1-
infected donors, the risk is 3.52% in these cou-
ples.12 HIV-1 is found primarily in white blood
cells and as cell-free virions in semen;13 therefore,
sperm-washing techniques can reduce HIV-1 lev-
els markedly before insemination. The clinical
value of sperm washing without seroconversion
was reported by Semprini et al in 1992,3 and
since then, several thousand published attempts
at IUI and IVF have been reported, to achieve
pregnancy and result in uninfected partners and
offspring.14–16
Sperm-washing techniques that separate motile
sperm from the round cell and seminal fluid frac-
tions include gradient centrifugation and swim-
up methods.3 Some modifications such as the
double-tube gradient method,17 the revised swim-
up method,18 or trypsin exposure19 can also re-
move HIV-1 completely. However, the efficiency
of sperm washing in removing HIV-1 varied ac-
cording to the seminal viral load in a recent study.20
The authors estimated the upper limit of HIV-1 to
be 5 × 104 copies/mL. Therefore, several solutions
Table 2. Comparison of the first in vitro fertilization/intracytoplasmic sperm injection cycle among three
groups using frozen sperma
Frozen semen HIV-discordant TESE/MESA p
No. of couples 68 14 36
Age (yr) 35.7 ± 5.7* 33.3 ± 4.9 31.2 ± 4.2* < 0.001*
Day 2 FSH (mIU/mL) 7.5 ± 4.8 5.1 ± 3.1 6.7 ± 3.0 NS
Total r-FSH (IU) 2,088 ± 1,045 2,002 ± 486 1,725 ± 804 NS
E2 on day of hCG 2,251 ± 1,483 2,715 ± 2,027 3,294 ± 2,402 NS
Retrieved oocytes 11.2 ± 7.4 14.1 ± 8.7 14.3 ± 8.7 NS
Mature oocytes 9.4 ± 6.0 12.9 ± 8.4 12.0 ± 7.1 NS
No. of 2-PN 6.9 ± 4.7 8.7 ± 6.5 8.3 ± 5.1 NS
Fertilization rate (%) 73.1 ± 20.5 66.8 ± 14.9 72.8 ± 19.2 NS
AES (Day 2) 9.4 ± 3.5 9.5 ± 3.5 9.1 ± 2.6 NS
Transferred embryos 3.4 ± 1.3 3.1 ± 0.9 3.7 ± 1.7 NS
CES 52.1 ± 29.1 53.8 ± 25.7 54.7 ± 27.8 NS
Clinical pregnancy (%) 30/68 (44.1) 4/14 (28.6) 20/36 (55.6) NS
Implantation rate (%) 17.6 ± 26.3 9.5 ± 16.7 18.2 ± 24.5 NS
No. of embryos frozen 2.3 ± 3.6 4.7 ± 5.9 3.4 ± 4.4 NS
aData are presented as n, n (%) or mean ± standard deviation. Kruskal–Wallis test was applied on most data followed by Mann–
Whitney U test. Clinical pregnancy per transvaginal oocyte retrieval cycle was compared by Pearson’s χ2 test. *p > 0.05. HIV = human
immunodeficiency virus; TESE/MESA = testicular sperm extraction/microscopic epididymal sperm aspiration; FSH = follicle-stimulating
hormone; NS = not significant; r-FSH = recombinant FSH; hCG = human chorionic gonadotropin; AES = average embryo score; CES =
cumulative embryo score.
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have been suggested in cases of high plasma viral
load: (1) to treat genital infections; (2) to modify
highly active antiretroviral therapy; and (3) to
evaluate the viral load in washed sperm. In our
subjects, we measured the viral load in the
washed sperm, but not in the raw semen. We
only referred to the plasma viral load as an indi-
cator, because usually there are subtle differences
in blood and seminal plasma HIV-1 RNA viral
loads.21
In this study, we used a real-time reverse 
transcription-PCR to detect HIV-1 RNA to
< 40 copies/mL. Some believe that HIV-1 might
be present in “seminal cells” in the form of DNA.22
Yet, the presence of HIV-1 in spermatozoa itself
has been a matter of debate. Using immunocyto-
chemistry, in situ hybridization at the electron
microscope level, and PCR, it has been demon-
strated that human sperm can incorporate HIV-1
using special receptors different from the com-
monly used CD4.23 Moreover, a recent study24
using nested PCR detected virus in 69.2% of pu-
rified sperm from HIV-1-positive men; in contrast,
these purified sperm were all negative for HIV-1
RNA. However, at the same time, a Japanese study5
using the same nested PCR failed to detect any
proviral DNA from all 36 samples of washed
sperm. On an epidemiological level, in > 5,000
ART cycles for HIV-1-discordant couples, none has
had seroconversion. However, on the molecular
level, the evidence seems to suggest some sero-
conversion risk still exists when these couples
use ART. One explanation for this discrepancy is
that the absence of HIV-1 in the women was prob-
ably due to their limited exposure to infected
sperm, rather than to the absence of HIV-1 in the
washed sperm themselves.
The pregnancy rates for our Taiwanese HIV-1-
discordant couples are compatible with other re-
ports around the world. Nine babies were born
and none was seroconverted. We also compared
the clinical outcomes between HIV-1-discordant
couples and HIV-1-negative controls. Men in the
TESE/MESA group had a significant fertility deficit
that forced them to seek help earlier. They were
relatively younger in age and had the highest
pregnancy rates (although still not significantly
different from the other two groups; perhaps due
to the small case number in the HIV-1 group)
(Table 2).
This is believed to be the first study in Taiwan
to provide ART to HIV-1-discordant couples. If
we can afford safe and efficient fertility services
for these people, they might consult us earlier
and achieve better results.
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